Sun Pharmaceutical Industries Ltd vs Cipla Ltd
SUNPHARMA vs CIPLA — Side-by-side fundamental comparison
SUNPHARMA
Sun Pharmaceutical Industries Ltd
₹1777.10
+0.00%
Score: 65.20/100
CIPLA
Cipla Ltd
₹1256.40
+0.00%
SUNPHARMA
Metric
CIPLA
| 65.20/100✓ | Bull Run Score | 🔒 Premium |
| 434K✓ | Market Cap (₹ Cr) | 123K |
| 37.57x | P/E Ratio | ✓22.62x |
| 16.86% | Return on Equity | ✓17.77% |
| 20.21% | ROCE | ✓22.72% |
| 0.07 | Debt/Equity | ✓0.01 |
| 0.89%✓ | Dividend Yield | 0.85% |
| 9.87% | Sales Growth 5Y | ✓9.97% |
| 23.78% | Profit Growth 5Y | ✓28.68% |
| 54.48%✓ | Promoter Holding | 29.21% |
| 1.49%✓ | 1Y Return | -0.70% |
| 31.77x | Industry P/E | 31.77x |
Sun Pharmaceutical Industries Ltd vs Cipla Ltd — Key Takeaways
Sun Pharmaceutical Industries Ltd (SUNPHARMA) has a Bull Run fundamental score of 65.20/100 compared to 59.00/100 for Cipla Ltd (CIPLA). CIPLA trades at a lower P/E of 22.62x vs 37.57x for SUNPHARMA. In terms of profitability, CIPLA has a higher ROE of 17.77% vs 16.86% for SUNPHARMA. This comparison is for educational purposes only. Please consult a SEBI-registered financial advisor before investing.
Data from NSE/BSE filings. Educational only. Not investment advice. Bull Run is not SEBI-registered.